Hepatocellular carcinoma (HCC) is the most common type of liver cancer and was the fourth leading cause of cancer death worldwide in
Long noncoding RNA (lncRNA) are transcripts longer than 200 nucleotides and do not have any apparent protein-coding poteintial. 4 Accumulating evidence shows that lncRNA play an important role in various physiological and pathological processes. 5 The mechanisms of lncRNA function have been shown to be multifactorial and largely dependent on their intracellular location. One molecular mechanism of the lncRNA enriched in the cytoplasm is participating in posttranscriptional regulation by acting as miRNA sponges. [6] [7] [8] LncRNA MIR22HG, which is mostly located in cytoplasm, is frequently deleted or hypermethylated, and commonly shows loss of heterozygosity in HCC. 9 MIR22HG has previously been demonstrated to be downregulated in hepatocellular carcinoma.
10
MIR22HG repressed hepatocellular carcinoma cell invasion by deriving miR-22 to target HMGB1 and binding with human antigen R (HuR). 9 Su et al 11 revealed that MIR22HG could inhibit cell survival signaling via oncogenes YBX1, MET and p21 in lung cancer. Cui et al 12 showed that MIR22HG negatively regulated miR-141-3p to upregulate DAPK1 expression and inhibited endometrial carcinoma cell proliferation. It is obvious that MIR22HG exerts its function through different mechanisms depending on the context diversity.
In the present study, we demonstrate that MIR22HG can inhibit HCC cell growth, migration and invasion through regulating the miR10a-5p/NCOR2 axis, which might provide a new therapeutic target for HCC treatment.
| MATERIAL S AND ME THODS

| Clinical specimens
A total of 120 liver cancer tissues and pair-matched adjacent non- 
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| Cell culture
HEK293T, Huh7, HepG2-C3A, SK-Hep-1 and MHCCLM3 cells were cultured at 37°C in a humidified incubator with 5% CO 2 in DMEM supplemented with 10% FBS, 100 U/mL penicillin and 100 μg/mL streptomycin.
| 5′ and 3′ RACE assay
5′ and 3′ RACE were used to determine the transcriptional initiation and termination sites of MIR22HG with a SMARTer RACE cDNA Amplification Kit (Clontech, CA, USA) as per the manufacturer's instructions. The sequences for the gene-specific PCR primers used for 5′ and 3′ RACE analysis are given in Table S1 . Table S1 .
| Northern blot
| Subcellular fractionation
The PARIS Kit (Life Technologies, MA, USA) was used to isolate the nuclear and cytoplasmic fractions. β-actin was used as the cytoplasmic endogenous control. U2 small nuclear RNA was used as the nuclear endogenous control. U6 was used to normalize the expression of miR10a-5p, and β-actin was used to normalize the expression of MIR22HG and NCOR2
| RNA extraction and quantitative RT-PCR
mRNA. The primer sequences used are shown in Table S1 .
| Lentivirus production and cell transfection
Negative control (NC), miR10a-5p mimics, miR10a-5p inhibitor, si-NC, si-MIR22HG and si-NCOR2 were all obtained from RiboBio. 
| Western blot analysis
After transfection for 48 hours, proteins were collected from cells using RIPA Buffer (Beyotime Biotechnology, Shanghai, China) con- 
| Statistical analysis
Statistical analyses were performed using IBM SPSS Statistics V19 package (Armonk, NY, USA). Data were presented as the mean ± SEM from multiple samples. The Student's t test or one-way ANOVA were used to evaluate the differences between different groups. Correlations between MIR22HG and NCOR2 or miR10a-5p
were analyzed by Pearson rank correlation. Survival was calculated using the Kaplan-Meier method and analyzed using the log-rank test. P < .05 was considered statistically significant.
| RE SULTS
| MIR22HG is significantly downregulated in hepatocellular carcinoma and low MIR22HG expression predicts poor prognosis
To explore the role of MIR22HG in HCC development, we first investigated the expression of MIR22HG in 120-pair HCC specimens ( Figure 1A ). We found that MIR22HG is distinctly downregulated in HCC specimens compared with adjacent nontumor liver tissues ( Figure 1B ). To investigate the clinical significance of MIR22HG expression in HCC, we analyzed the relationship between clinicopathologic features and MIR22HG expression levels in HCC cases.
The MIR22HG level was negatively correlated with the level of AFP (P = .012) ( Table 1) . Importantly, downregulation of MIR22HG expression was associated with tumor thrombus (P = .05; Table 1 ).
Furthermore, patients with lower MIR22HG level exhibited shorter overall survival (OS) (P = .045) and worse disease-free survival than 
| MIR22HG inhibited hepatocellular carcinoma cell growth, migration and invasion
Next, to investigate the potential biological function of MIR22HG, we stably silenced MIR22HG in HepG2-C3A and MHCCLM3 cells ( Figure 2A ). CCK8 assays showed that downregulation of MIR22HG
significantly promoted liver cancer cell growth ( Figure 2B ), and colony formation assays were consistent with this result ( Figure 2C ).
Moreover, transwell assays indicated that knockdown of MIR22HG
promoted the migration and invasion of cells compared with the control ( Figure 2D ). Wound healing assays showed that downregulation of MIR22HG promoted cell migration in HepG2-C3A and MHCCLM3 cells ( Figure 2E ).
Next, we constructed pCDH-MIR22HG expression plasmid and transfected it into Huh7 and SK-Hep-1 cells ( Figure 3A ). CCK8 assays showed that MIR22HG overexpression significantly decreased 
| MIR22HG directly interacts with miR-10a-5p
To further uncover the molecular mechanism by which MIR22HG exerts its biological function in HCC, we analyzed the microRNA (miRNA) binding sites on MIR22HG using the TargetScan algorithm. At the same time, we analyzed the correlation between MIR22HG with the miRNA candidates.
Finally, 13 candidate miRNA were selected following this analytical strategy ( Figure S2A ). To explore the potential interaction of candidate miRNA and MIR22HG, we transfected these 13 miRNA mimics with psicheck2-MIR22HG plasmids into HEK-293T cells, respectively. We found that miR10a-5p mimic markedly altered the luciferase activity of the construct containing MIR22HG transcript ( Figure 4A ). Ago-2 RIP assays
showed that MIR22HG and miR10a-5p could simultaneously be pulled down from the Ago-2 complex, which is a key component of the RNA-induced silencing complex (RISC) ( Figure 4B ).
To investigate the interaction between MIR22HG and miR10a-5p, we performed several experiments. First, we evaluated the expression of MIR22HG and miR10a-5p in 38 pairs of HCC tissues and found that miR10a-5p expression was inversely correlated with MIR22HG expression in 38 pairs of HCC tissues (r = −.365, P = .183; Figure S2B ). Second, we constructed luciferase reporter vectors containing either wild-type 
| MIR22HG acts as a competing endogenous RNA and regulates miR10a-5p downstream target NCOR2 by competitively binding to miR10a-5p
To elucidate the molecular mechanism underlying miR10a-5p exerting its effects on HCC cells, we searched for candidate downstream targets of miR10a-5p using combined analyzing bioinformatics tools (miRTarBase, miRbase and miRDB) ( Figure S2C ) and 13 candidates were selected. qRT-PCR analysis showed that MIR22HG knockdown decreased NCOR2 while MIR22HG overexpression upregulated NCOR2 ( Figure S2D , E). According to predictions from TargetScan, we found that there was a potential binding site of miR10a-5p in the 3′UTR of NCOR2 and constructed a luciferase reporter vector containing either wild or mutant NCOR2 3′-UTR ( Figure 4F ). As shown in Figure 4G , miR10a-5p mimic significantly suppressed the activity of NCOR2-wild-type reporter, while miR10a-5p inhibitor significantly increased the activity of NCOR2-wild-type reporter.
However, neither miR10a-5p mimic nor miR10a-5p inhibitor have any effect on the luciferase activity of vector containing mutant miR10a-5p binding site ( Figure 4G ). Moreover, the NCOR2 transcript level was negatively correlated with the miR10a-5p expression level (P = .132, r = −.252) ( Figure S2F ). Western blot analysis showed that silenced MIR22HG decreased NCOR2 protein while MIR22HG overexpression upregulated NCOR2 protein, and miR10a-5p transfection could reverse the effect of MIR22HG on NCOR2 protein ( Figure 4H ). Importantly, Pearson's correlation analysis showed that NCOR2 mRNA was positively correlated with MIR22HG in HCC tissues (P < .0001, r = .678; Figure 4I ). In summary, MIR22HG might positively regulate NCOR2 expression by competitively binding to miR10a-5p.
| MIR22HG inhibits hepatocellular carcinoma cell growth, invasion and metastasis through targeting the miR10a-5p/NCOR2 axis
Many reports have indicated that miR10a-5p acts as an oncogene during cancer progression, [13] [14] [15] [16] [17] but the role of miR10a-5p in HCC remains unclear. Here, we found that miR10a-5p could promote the growth, migration and invasion of liver cancer cells ( Figure 5A-C) .
Next, we investigated the functional interaction of MIR22HG and miR10a-5p. As shown in Figure 5A , MIR22HG inhibited growth and colony formation of SK-Hep-1, while miR10a-5p abrogated the inhibitory effects of MIR22HG. Similarly, miR10a-5p also reversed the inhibitory effects of MIR22HG on migration and invasion of liver cancer cells ( Figure 5C ). Consistent with these results, miR10a-5p
inhibitor could reverse the promotion of MIR22HG knockdown on growth, migration and invasion of liver cancer cells ( Figure S3A -C).
Because NCOR2 was identified as a target downstream MIR22HG/ miR10a-5p axis, we next investigated whether MIR22HG regulates HCC cell growth, migration and invasion through NCOR2. The results showed that MIR22HG overexpression suppressed cell growth, migration and invasion, while knockdown NCOR2 could partially reverse these effects ( Figure 5D-F) . In agreement with these results, TA B L E 1 Clinical parameters of the patients with hepatocellular carcinoma (HCC) who were included in this study overexpression of NCOR2 could partly weaken the promotion of growth, migration and invasion induced by MIR22HG knockdown (Figure S3D-F) . Overall, these results suggested that MIR22HG
regulates HCC cell growth, migration and invasion by regulating the miR10a-5p/NCOR2 axis.
| MIR22HG regulates epithelial-mesenchymal transition through the miR10a-5p/NCOR2/Wnt/β-catenin pathway
NCOR2 is a nuclear receptor co-repressor that mediates transcriptional silencing of certain target genes. 18 It has been re- Metastasis is an important characteristic of cancer and is the leading cause of death for approximately 90% of cancer patients.
Complicated signaling pathways are involved in tumor metastasis.
Among them, epithelial-mesenchymal transition (EMT) is a major pathway affecting metastasis. [22] [23] [24] [25] Previous studies indicated that Wnt/β-catenin pathway plays an important role in the EMT of cancer cells. 26, 27 Hence, we speculated that MIR22HG might inhibit EMT by inactivating the Wnt/β-catenin pathway. We detected the EMT markers following MIR22HG overexpression or knockdown.
Western blot analysis showed that MIR22HG knockdown increased mesenchymal markers N-cadherin and vimentin, and decreased epithelial marker E-cadherin, while these effects could be partially restored by miR10a-5p inhibitor ( Figure 6B ). Moreover, overexpressing MIR22HG induced expression of epithelial markers and reduced expression of mesenchymal markers. These effects could be partially restored by miR10a-5p mimic. Consistent with western blot analysis, immunofluorescence experiment staining of vimentin also suggested similar results ( Figure 6C ). All these results demonstrated that MIR22HG regulated HCC EMT by competitively binding miR10a-5p and inactivating Wnt/β-catenin pathway ( Figure 6D ).
| D ISCUSS I ON
In recent years, emerging research has revealed that lncRNA play an Consistent with this finding, we found that MIR22HG transcript was significantly decreased in the HCC tissues, and low MIR22HG level was related to shorter overall survival (OS) and worse disease-free survival. Moreover, MIR22HG was negatively correlated with AFP (P = .012). Recent studies have shown that AFP is not just a biomarker for HCC but also an ardent promoter of liver cancer growth and progression. 31, 32 We used a combination of AFP and MIR22HG
level to predict the prognosis of liver cancer patients. First, ROC curve analysis showed that AFP + MIR22HG could more efficiently predict the prognosis of liver cancer patients ( Figure S4A ). At the same time, after univariate Cox proportional hazards regression analysis, AFP + MIR22HG was found to be more significantly correlated with the OS of HCC patients (P = .015) ( Figure S4B ). It turns out that combination with AFP + MIR22HG has a better prediction efficiency. These results indicated that MIR22HG may serve as a potential diagnostic and prognostic biomarker to improve HCC patients' outcome. Moreover, MIR22HG inhibited HCC growth, migration and invasion, suggesting that MIR22HG might act as a tumor suppressor in HCC.
One major molecular mechanism of lncRNA is acting as a molecular sponge for miRNA. In this study, combining bioinformatic analyses and luciferase reporter assays, we demonstrated that MIR22HG directly binds to miR10a-5p and inhibits miR10a-5p expression. Previous studies showed that miR10a-5p could play an important role in neoplasms. For example, Liu et al 15 found that F I G U R E 2 MIR22HG knockdown promoted hepatocellular carcinoma (HCC) cell growth, migration and invasion. A, The level of MIR22HG in HepG2-C3A and MHCCLM3 cells after transfection with shMIR22HG or control was determined by quantitative PCR. B, Cell Counting Kit-8 (CCK-8) assays showed that MIR22HG knockdown promoted HCC growth. C, Colony formation assays showed that MIR22HG knockdown promoted HCC cell growth. D, Transwell assays showed that MIR22HG knockdown promoted migration and invasion of HCC cells. Results were expressed as cell numbers per field. E, Wound-healing assay showed that MIR22HG knockdown resulted in a faster closing of scratch wound. Results were expressed as wound healing percentage normalized to control. The error bars in all graphs represented SEM, and each experiment was repeated at least 3 times. *P < .05, **P < .01 and ***P < .001. Control, negative control F I G U R E 3 Overexpression of MIR22HG suppressed hepatocellular carcinoma (HCC) cell growth, migration and invasion. A, Quantitative PCR analysis of MIR22HG expression after MIR22HG overexpression. B, CCK8 assays and colony formation assays showed that MIR22HG overexpression inhibited liver cancer cells growth. C-E, Transwell and wound healing assays showed that MIR22HG overexpression inhibited migration and invasion of liver cancer cells. The error bars in all graphs represented SEM, and each experiment was repeated at least 3 times. *P < .05, **P < .01 and ***P < .001. Vector, empty vector In addition, miR-10a was reported to suppress colorectal cancer metastasis by targeting MMP14 and ACTG1. 13 These studies suggest that miR-10a can act as an oncogene or tumor suppressor according to content difference in cancers. However, the role of miR-10a in HCC remains unclear. Our study provides the first evidence that miR10a-5p promotes liver cancer cell growth, migration and invasion of HCC cells. Furthermore, miR10a is inversely correlated with MIR22HG in liver cancer tissues. Overexpression of miR10a-5p reverses the anti-metastatic ability of MIR22HG.
F I G U R E 4 MIR22HG acts as a competing endogenous RNA and regulates NCOR2 expression by competitively binding miR10a-5p. A, 13 microRNA mimics transfected with psicheck2-MIR22HG plasmids into HEK-293T cells, respectively. miR10a-5p mimic can reduce the luciferase activity of MIR22HG. B, RIP assay indicated that both MIR22HG and miR10a-5p were significantly enriched in Ago2 immunoprecipitate. Empty vector was used as a nonspecific control. IgG acted as an internal control. C, Bioinformatics prediction of miR10a-5p binding sites in MIR22HG sequence using miRbase. D, Relative luciferase activities of wild-type (WT) and mutated (MUT) MIR22HG reporter plasmid in HEK-293T cells co-transfected with miR10a-5p mimic or inhibitor. E, miR10a-5p expression was determined by quantitative RT-PCR after MIR22HG overexpression or knockdown. F, Bioinformatics prediction of miR10a-5p binding sites in NCOR2 3′UTR sequence using miRbase. G, Relative luciferase activities of wild-type (WT) and mutated (MUT) NCOR2 3′UTR reporter plasmid in HEK-293T cells co-transfected with miR10a-5p mimic or inhibitor. H, Western blot detected NCOR2 protein levels after MIR22HG or miR10a-5p manipulation as indicated in the figure. I, Pearson's correlation analysis of the relationship between MIR22HG and NCOR2 mRNA expression levels in liver cancer tissues. The error bars in all graphs represent SEM, and each experiment was repeated at least 3 times. *P < .05, **P < .01 and ***P < .001
These results indicated that miR10a-5p could act as a downstream target of MIR22HG in liver cancer cells.
We further explore the downstream signaling pathway of miR10a-5p in HCC. Through bioinformatic analyses, qPCR, luciferase reporter assays and western blot analysis, we demonstrated that NCOR2 was the target of miR10a-5p in liver cancer cells. NCOR2, nuclear receptor corepressor 2 (also known as SMRT), mediates liver cancer cells of certain target genes. 18, 20 Chao Qu et al 20 have shown that NCOR2 can bind with TBL1/TBLR1, which disrupts the binding of β-catenin to TBL1/TBLR1 complex, thereby inactivating the F I G U R E 5 MIR22HG inhibited hepatocellular carcinoma (HCC) cell growth, migration and invasion by inhibiting the miR10a-5p/ NCOR2 axis. A-C, miR10a-5p partially reversed the effects of MIR22HG on the growth, migration and invasion of liver cancer cells. D-F, NCOR2 partially restored the effects of MIR22HG on the growth, migration and invasion of liver cancer cells. The error bars in all graphs represented SEM, and each experiment was repeated at least 3 times. *P < .05, **P < .01 and ***P < .001
Wnt/β-catenin pathway. Here, we also found that overexpression of NCOR2 significantly decreased TOP/FOP activity, indicating that the Wnt/β-catenin pathway was inhibited by NCOR2 in HCC cells. suppressed EMT by modulating the Wnt/β-catenin pathway.
In conclusion, we explored a new mechanism of lncRNA MIR22HG in HCC. MIR22HG worked as a tumor suppressor that inhibited the tumorigenesis and progression of HCC through the MIR22HG/miR10a-5p/NCOR2 axis, and is a potential therapeutic target for HCC.
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Linhui Liang https://orcid.org/0000-0002-1284-138X F I G U R E 6 MIR22HG inhibited epithelial-mesenchymal transition (EMT) by competitively binding miR10a-5p and activating the Wnt/β-catenin pathway. A, Dual-luciferase assay showed that MIR22HG and NCOR2 inhibited TOP/FOP reporter activity in SK-Hep1 and MHCCLM3 cells. B, Western blot assays were used to analyze EMT marker expression after MIR22HG overexpression or knockdown with/without miR10a-5p mimic and inhibitor transfection. C, Immunofluorescence assays determined the vimentin level upon MIR22HG overexpression or knockdown with/without miR10a-5p mimic and inhibitor transfection. D, A schematic model depicting the molecular mechanism of MIR22HG in hepatocellular carcinoma (HCC)
